Recently, 5-Aminolevulinic Acid Hexyl Ester Hydrochloride injection produced by Photocure ASA Company has been included among the pilot drugs, making the number of pilot drugs in Lecheng’s real-...

On November 26, as reviewed by the NMPA, the registration of Johnson&Johnson Vision Catalys precision laser system was approved, which was the second innovative medical product to be approved base...

On March 3, the pilot program of real-world data application of Lecheng witnessed a new breakthrough. The NMPA reviewed and approved the registration application of thermal steam treatment equipment a...

Recently, through the prioritized review and approval procedure, the NMPA conditionally approved the marketing of Pralsetinib capsule, a Class 1 innovative drug declared by Blueprint Medicines Corpora...

On March 26, the NMPA reviewed and approved the registration of XEN Glaucoma treatment system of the US Allergen Company.In order to promote the reform of China’s medical device evaluation and a...